Active	Status	Sponsor type	Region	Phase	Filter
18 Active 6 Inactive 24 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Black, Peter C
TURBT, NCT06111235: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following	Recruiting	3	364	Canada, US	Cretostimogene Grenadenorepvec, CG0070, n-dodecyl-B-D-maltoside, DDM	CG Oncology, Inc.	Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer, Urothelial Carcinoma	01/28	01/30
NCT03945162: Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients	Recruiting	2	125	Canada, US	Ruvidar® (TLD-1433) Bladder infusion and PDT	Theralase® Technologies Inc., University Health Network, Toronto, Pharma eMarket	Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG	06/25	12/25
NCT03988309: STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA	Active, not recruiting	N/A	554	Canada, US	Cxbladder	Pacific Edge Limited	Hematuria, Urothelial Carcinoma	12/24	12/24
Järvinen, Riikka
No trials found
Seppänen, Marjo
No trials found
Haapiainen, Henry
No trials found